WAT
Status-Quo-PlayerWaters Corporation
$324.68
+1.45%
as of 13 Apr
Power Core
The moat in one sentence: Waters' power core is the regulatory validation lock-in created when customers embed its instruments and Empower software into FDA-filed manufacturing and quality control methods.
Direction of Movement
Lateral Trajectory With Optionality in Biologics and Software
ROC 200
-12.5%
WAT
Waters Corporation
$324.68
+1.45%
as of 13 Apr
DCF Fair Value: $254.12
mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.
Company Profile
Waters Corporation is a leading provider of analytical instruments and software solutions for scientific research and quality control in laboratory environments worldwide. The company specializes in liquid chromatography, mass spectrometry, and thermal analysis technologies that deliver essential molecular and physical property information to support product development and quality assurance. Waters serves three primary markets: biopharmaceutical firms utilizing its instruments for drug development and regulatory compliance, industrial clients across various manufacturing sectors, and academic and government research institutions. The company's analytical instruments are considered gold standards in their applications, particularly in liquid chromatography-mass spectrometry for biopharmaceutical research. In early 2026, Waters is undergoing a significant merger with BD's life science and diagnostics business, which will expand its portfolio and market reach into diagnostics and discovery-related life science tools, fundamentally broadening the company's service offerings and customer concentrations.